Implementation of the App Tät®II for Treatment of Urgency and Mixed Urinary Incontinence
Launched by UMEÅ UNIVERSITY · Jun 23, 2025
Trial Information
Current as of August 25, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how well a smartphone app called Tät®II works to help women manage urgency and mixed urinary incontinence—conditions where you suddenly feel the need to urinate or have both sudden urges and leaks related to stress. The study wants to see if using this app after visiting a regular healthcare provider is a practical and effective way to treat these symptoms. Women who join the study will use the app for 15 weeks and will be asked to complete online surveys about their symptoms before starting, right after finishing the treatment, and again one year later to see how they’re doing over time.
To be part of the study, you need to be a woman aged 18 or older who has been diagnosed with urgency or mixed urinary incontinence by a regular doctor. You also need to have signed a consent form agreeing to participate. The study is not open to women who are pregnant, have given birth in the last six months, have painful urges, difficulty emptying their bladder, blood in their urine, or need further medical tests for their incontinence. If you join, you’ll mainly be using the app at home and sharing how your symptoms change through online questionnaires. This study is still recruiting participants, so if this sounds like something that might help you, you could consider talking to your healthcare provider about it.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Female gender
- • Age ≥18 years
- • Symptoms of urgency urinary incontinence or mixed urinary incontinence
- • Medical evaluation and documentation of urinary incontinence by ordinary doctor
- • Signed informed consent
- Exclusion Criteria:
- • Pregnancy
- • Childbirth in the last 6 months
- • Painful urges
- • Difficulties emptying the bladder
- • Blood in urine
- • Need of further investigation concerning the urinary incontinence, according to the clinical doctor
About Umeå University
Umeå University, a leading research institution in Sweden, is dedicated to advancing healthcare through innovative clinical trials and translational research. With a strong emphasis on interdisciplinary collaboration, the university harnesses cutting-edge technology and expert knowledge across various fields to address critical health challenges. Its commitment to ethical standards and patient safety ensures that all clinical trials conducted under its auspices are designed to generate robust scientific evidence, ultimately contributing to improved health outcomes and informed medical practices. Umeå University strives to foster a dynamic research environment that supports the development of new therapies and enhances the understanding of complex health issues.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
östersund, , Sweden
Patients applied
Trial Officials
Ina Asklund, MD, PhD
Principal Investigator
Umeå University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported